Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Robert John Motzer, Camillo Porta, Masatoshi Eto, Thomas B. Powles, Viktor Grünwald, Thomas E. Hutson and 24 more
- Rank
- 15 of 493
- Percentile
- top 3.1%
- Where
- Journal of Clinical Oncology, 2024
- Citations
- 190
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.